A Hall & Wilcox team (led by Corporate and commercial section head, John Hutchinson, and including Chris Brown (Partner), Caroline Raw (Senior Associate), and Max Chung and Rebecca Schot-Guppy (Lawyers)) has provided legal support to Moelis Australia in its acquisition of real estate funds manager, Armada Funds Management. The transaction completed on 1 June for consideration valued at A$29.5 million (comprising A$9.8m cash and shares in Moelis Australia).
Monthly Archives: June 2017
Clients May be Interested to Submit Comments on a Proposed Requirement that AOs Post Surveys and Plans of Correction on the AOs Websites
On April 14, 2017, CMS issued the FY 2018 Medicare Hospital IPPS Proposed Rule that includes numerous proposed changes. However, there is a very small provision in this proposed rule that organizations may not be aware of …. especially those that are not hospitals and who normally would not look at the Hospital IPPS rule.
Federal Financial Monitoring Service (hereinafter – Rosfinmonitoring) developed a draft Order concerning disclosure of information by legal entities upon request of authorized state bodies (hereinafter – Draft order)1. The Draft order has been made public at the official website on 27 April 2017. At the moment the Draft order passes the stage regulatory impact estimation prior to entering to the Russian Government consideration..
The Draft order has been developed in the furtherance of art. 6.1. of the Federal law dated 07.08.2001 No. 115-FZ (hereinafter – 115-FZ)2, which stipulates obligation of the companies to submit upon request of authorized bodies documented information on the company’s ultimate beneficial owners as well as information regarding the measures taken in order to ascertain the information on the company’s ultimate beneficial owners (hereinafter – Information).
On 28 and 30 March 2017 FAS Russia passed a number of decisions bringing pharmaceutical companies to liability for violation of the Federal law No. 38-FZ of 13 March 2006 “On advertising” (the “Advertising Law”). The cases were opened following the results of the study of commercials broadcasted on television. The companies involved in these cases were: AO “Servier” (brand “Detralex”); OOO “Johnson & Johnson” (brand “Motilium”); AO “Bayer” (brand “Rennie”); Astellas Pharma Europe B.V. (the Netherlands, brands “Fosfalugel” and “De-nol”); OOO “Valiant” (brand “Holisal”); and ZAO “Sandoz” (brand “Exoderil”).
On May 31st, Davis Malm participated in the 10th Anniversary Lawyers Have Heart 5k Road Race and Summer Celebration to benefit the American Heart Association. Out of 101 participating Boston firms, Davis Malm had the 9th highest fundraising total at the time of the race. This was Davis Malm’s seventh consecutive year participating in the race.
Davis Malm shareholder Patrick T. Clendenen and associate Daniel T. Janis, former and current Executive Leadership Committee members respectively, were part of the Davis Malm team. The team was comprised of attorneys, staff, friends, and clients, and had 22 people participate in the race.